Hypertrophic Cardiomyopathy List of articles

ELIQUENT Japan > Hypertrophic Cardiomyopathy

2026.02.17

White,medical,pills,and,tablets,spilling,out,of,a,drug

Points to Consider for the Development of Drugs for Hypertrophic Cardiomyopathy (Early Consideration)

Introduction Hypertrophic cardiomyopathy (HCM) is a condition marked by abnormal thickening of the ventricular […]

COMPANY

Company Name: Eliquent Japan, Inc.
Location: Shinjuku i-Land Tower 41F, 6-5-1 Nishi Shinjuku, Shinjuku-ku 163-1341 Tokyo, Japan
Representative Director, CEO: Shunsuke Iwano
Business Scope: Regulatory Consulting
 Phone:+81-3-6304-5570